Cortes, J. E., Kantarjian, H. M., Brümmendorf, T. H., Kim, D., Turkina, A. G., Shen, Z., . . . Gambacorti-Passerini, C. (2011). Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib. Blood.
Chicago-stil citatCortes, Jorge E., et al. "Safety and Efficacy of Bosutinib (SKI-606) in Chronic Phase Philadelphia Chromosome–positive Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Imatinib." Blood 2011.
MLA-referensCortes, Jorge E., et al. "Safety and Efficacy of Bosutinib (SKI-606) in Chronic Phase Philadelphia Chromosome–positive Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Imatinib." Blood 2011.